Cargando…

Narrative-based computational modelling of the Gp130/JAK/STAT signalling pathway

BACKGROUND: Appropriately formulated quantitative computational models can support researchers in understanding the dynamic behaviour of biological pathways and support hypothesis formulation and selection by "in silico" experimentation. An obstacle to widespread adoption of this approach...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guerriero, Maria Luisa, Dudka, Anna, Underhill-Day, Nicholas, Heath, John K, Priami, Corrado
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2678071/ https://www.ncbi.nlm.nih.gov/pubmed/19368721 http://dx.doi.org/10.1186/1752-0509-3-40

Ejemplares similares

Gp130 Promotes Inflammation via the STAT3/JAK2 Pathway in Allergic Conjunctivitis
por: Bao, Jiayu, et al.
Publicado: (2023)

Sepsis induces interleukin 6, gp130/JAK2/STAT3, and muscle wasting
por: Zanders, Lukas, et al.
Publicado: (2021)

Modulation of the IL-6-Signaling Pathway in Liver Cells by miRNAs Targeting gp130, JAK1, and/or STAT3
por: Servais, Florence A., et al.
Publicado: (2019)

Joint disease caused by defective gp130-mediated STAT signaling
por: Naka, Tetsuji, et al.
Publicado: (2002)

A GP130-Targeting Small Molecule, LMT-28, Reduces LPS-Induced Bone Resorption around Implants in Diabetic Models by Inhibiting IL-6/GP130/JAK2/STAT3 Signaling
por: Liu, Qi-qi, et al.
Publicado: (2023)

Cytoplasmic LMO2-LDB1 Complex Activates STAT3 Signaling through Interaction with gp130-JAK in Glioma Stem Cells
por: Park, Cheol Gyu, et al.
Publicado: (2022)

CD9 exacerbates pathological cardiac hypertrophy through regulating GP130/STAT3 signaling pathway
por: Li, Yue, et al.
Publicado: (2023)

NOTCH Activation via gp130/STAT3 Signaling Confers Resistance to Chemoradiotherapy
por: Koerdel, Kristin, et al.
Publicado: (2021)

Expression of Carboxypeptidase X M14 Family Member 2 Accelerates the Progression of Hepatocellular Carcinoma via Regulation of the gp130/JAK2/Stat1 Pathway
por: Ye, Yanshuo, et al.
Publicado: (2020)

The Dynamics of Signal Triggering in a gp130-Receptor Complex
por: Matadeen, Rishi, et al.
Publicado: (2007)

Regulatory effect of anti-gp130 functional mAb on IL-6 mediated RANKL and Wnt5a expression through JAK-STAT3 signaling pathway in FLS
por: Miao, Ping, et al.
Publicado: (2018)

Oncostatin M suppresses browning of white adipocytes via gp130-STAT3 signaling
por: van Krieken, Pim P., et al.
Publicado: (2021)

Cytokine Receptor-Like Factor 1 (CRLF1) Protects against 6-Hydroxydopamine Toxicity Independent of the gp130/JAK Signaling Pathway
por: Looyenga, Brendan D., et al.
Publicado: (2013)

Iron-dependent CDK1 activity promotes lung carcinogenesis via activation of the GP130/STAT3 signaling pathway
por: Kuang, Yanbin, et al.
Publicado: (2019)

STAT3 Is Required for the gp130-mediated Full Activation of the c-myc Gene
por: Kiuchi, Nobuo, et al.
Publicado: (1999)

Differential Role of gp130-Dependent STAT and Ras Signalling for Haematopoiesis Following Bone-Marrow Transplantation
por: Kroy, Daniela C., et al.
Publicado: (2012)

Breast Cancer-Derived Exosomes Alter Macrophage Polarization via gp130/STAT3 Signaling
por: Ham, Sunyoung, et al.
Publicado: (2018)

Bromodomain Inhibition Attenuates the Progression and Sensitizes the Chemosensitivity of Osteosarcoma by Repressing GP130/STAT3 Signaling
por: Jiang, Yafei, et al.
Publicado: (2021)

JAK-STAT Signalling Pathway in Cancer
por: Brooks, Andrew J., et al.
Publicado: (2020)

JAK/STAT pathway and molecular mechanism in bone remodeling
por: Sanpaolo, Eliana Rita, et al.
Publicado: (2020)

Correction: Cytokine Receptor-Like Factor 1 (CRLF1) Protects against 6-Hydroxydopamine Toxicity Independent of the gp130/JAK Signaling Pathway
por: Looyenga, Brendan D., et al.
Publicado: (2014)

p42/p44-MAPK and PI3K are sufficient for IL-6 family cytokines/gp130 to signal to hypertrophy and survival in cardiomyocytes in the absence of JAK/STAT activation
por: Fahmi, Ahmed, et al.
Publicado: (2013)

Proteasome Inhibitor YSY01A Abrogates Constitutive STAT3 Signaling via Down-regulation of Gp130 and JAK2 in Human A549 Lung Cancer Cells
por: Huang, Wei, et al.
Publicado: (2017)

Inhibition of GP130/STAT3 and EMT by combined bazedoxifene and paclitaxel treatment in ovarian cancer
por: Park, Sun-Ae, et al.
Publicado: (2022)

Cortical bone maturation in mice requires SOCS3 suppression of gp130/STAT3 signalling in osteocytes
por: Walker, Emma C, et al.
Publicado: (2020)

gp130/STAT3 signaling is required for homeostatic proliferation and anabolism in postnatal growth plate and articular chondrocytes
por: Liu, Nancy Q., et al.
Publicado: (2022)

The Role of gp130 Cytokines in Tuberculosis
por: Ritter, Kristina, et al.
Publicado: (2020)

New insights into the role and signalling processes of gp130
por: Rose-John, Stefan
Publicado: (2011)

The two facets of gp130 signalling in liver tumorigenesis
por: Schmidt-Arras, Dirk, et al.
Publicado: (2021)

The Drosophila JAK-STAT pathway
por: Zeidler, Martin P, et al.
Publicado: (2013)

Evolution of the JAK-STAT pathway
por: Liongue, Clifford, et al.
Publicado: (2013)

The JAK-STAT pathway at 20
por: Darnell, Jr., James E.
Publicado: (2012)

Defective Gp130-Mediated Signal Transducer and Activator of Transcription (Stat) Signaling Results in Degenerative Joint Disease, Gastrointestinal Ulceration, and Failure of Uterine Implantation
por: Ernst, Matthias, et al.
Publicado: (2001)

Raloxifene inhibits pancreatic adenocarcinoma growth by interfering with ERβ and IL-6/gp130/STAT3 signaling
por: Pozios, Ioannis, et al.
Publicado: (2020)

The protective effect of WKYMVm peptide on inflammatory osteolysis through regulating NF‐κB and CD9/gp130/STAT3 signalling pathway
por: Hu, Junxian, et al.
Publicado: (2019)

GP130 Cytokines in Breast Cancer and Bone
por: Omokehinde, Tolu, et al.
Publicado: (2020)

Roles of IL-6-gp130 Signaling in Vascular Inflammation
por: Hou, Tieying, et al.
Publicado: (2008)

An overview of JAK/STAT pathways and JAK inhibition in alopecia areata
por: Lensing, Maddison, et al.
Publicado: (2022)

JAK-STAT pathway and myogenic differentiation
por: Jang, You-Na, et al.
Publicado: (2013)

JAK-STAT pathway inhibitors in dermatology()
por: Miot, Hélio Amante, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_kv3jiccumdqebh1aj3f2kt04mp